A newly synthesized nanoplatform of hyaluronic acid and chitosan nanoparticles was applied to improve the therapeutic efficacy and protection of bone marrow MSCs against cisplatin-induced nephrotoxicity in rats.
[International Journal Of Pharmaceutics]